That's a good question! Note this author's conclusion: Quote: "Just as importantly, shares of the company currently trade at reasonable valuations. All things considered, ISEC Healthcare is certainly a buy in my books..." Unquote
If so, wonder whether David Kuo & his team at MF did recommend a 'buy' for it?
As seen from above, ISEC net profit has jumped from S$2.7mil in 2015 to S$7.9 mil in 2017.
The topline, bottomline n dividend have been on the uptrend too. 1st quarter result for 2018
has been an impressive S$2.1 mil. Looks like 2018 will be another good year for the company.
Company has cash of S$27.0 mil and no debt.
Above are for sharing only ... not a buy or sell call